Latest filing published 29 Apr 2022 for U.S. Stem Cell, Inc., €9,333.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Gregory Knutson: trading record in brief
All filings by Gregory Knutson on record concern U.S. Stem Cell, Inc., in the capacity of board member. Between 1 April 2020 and 25 April 2022, the trades on record add up to 5 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 29 April 2022, the filings show a share grant worth €9,333 in U.S. Stem Cell, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Gregory Knutson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,500,000 shares@ US$0.004100.0% of flowCommon StockSEC:0001185185-22-000518:0
- 25,000,000 shares@ €0.007287.7% of flowCommon StockSEC:0001185185-22-000329:0
- 1,445,647 shares@ US$0.00612.34% mcap3.9% of flowCommon StockSEC:0001185185-21-001026:0
3 of 3 declarations